Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	AXS-07	0	441
Total, all-cause mortality	Meloxicam	0	433
Total, all-cause mortality	Rizatriptan	0	434
Total, all-cause mortality	Placebo	0	218
Total, other adverse events	AXS-07	49	441
Total, other adverse events	Meloxicam	50	433
Total, other adverse events	Rizatriptan	67	434
Total, other adverse events	Placebo	13	218
Total, serious adverse events	AXS-07	1	441
Total, serious adverse events	Meloxicam	0	433
Total, serious adverse events	Rizatriptan	0	434
Total, serious adverse events	Placebo	0	218

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03896009/event-totals